{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:08:50Z","timestamp":1787267330609,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020737","name":"Renji Hospital","doi-asserted-by":"publisher","award":["2021ZYA022"],"award-info":[{"award-number":["2021ZYA022"]}],"id":[{"id":"10.13039\/501100020737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ijid.2022.10.004","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T07:17:58Z","timestamp":1665559078000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7149-1260","authenticated-orcid":false,"given":"Ruo-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Yong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Wen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Tian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.10.004_bib0001","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.transproceed.2016.05.017","article-title":"Risk evaluation and outcome of Pneumocystis jirovecii pneumonia in kidney transplant patients","volume":"48","author":"Brakemeier","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijid.2022.10.004_bib0002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.phrs.2018.06.010","article-title":"Prophylaxis and treatment of Pneumocystis jirovecii pneumonia after solid organ transplantation","volume":"134","author":"Brakemeier","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ijid.2022.10.004_bib0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/AAC.39.1.28","article-title":"Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients","volume":"39","author":"Chin","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.10.004_bib0004","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.42.5.995","article-title":"Prevention of infection due to Pneumocystis carinii","volume":"42","author":"Fishman","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.10.004_bib0005","doi-asserted-by":"crossref","first-page":"e13587","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijid.2022.10.004_bib0006","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/23744235.2016.1225980","article-title":"High Pneumocystis jirovecii colonization rate among haemodialysis patients","volume":"49","author":"Fritzsche","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijid.2022.10.004_bib0007","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/nep.12054","article-title":"Pneumocystis jirovecii colonization among renal transplant recipients","volume":"18","author":"Fritzsche","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ijid.2022.10.004_bib0008","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.chest.2020.05.558","article-title":"Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases","volume":"158","author":"Ghembaza","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2022.10.004_bib0009","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijid.2022.10.004_bib0010","doi-asserted-by":"crossref","first-page":"e14322","DOI":"10.1111\/ctr.14322","article-title":"Six-month risk of Pneumocystis pneumonia following acute cellular rejection: a case-control study in solid organ transplant recipients","volume":"35","author":"Hosseini-Moghaddam","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijid.2022.10.004_bib0011","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.mayocp.2020.07.029","article-title":"Host Factors and outcomes in hospitalizations for Pneumocystis jirovecii pneumonia in the United States","volume":"96","author":"Kanj","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijid.2022.10.004_bib0012","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijid.2022.10.004_bib0013","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12882-019-1407-x","article-title":"Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome","volume":"20","author":"Kim","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ijid.2022.10.004_bib0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/1346-8138.15724","article-title":"Adverse effects of trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis pneumonia in dermatology","volume":"48","author":"Kokubu","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.ijid.2022.10.004_bib0016","article-title":"Efficacy and safety of trimethoprim-sulfamethoxazole for the prevention of pneumocystis pneumonia in human immunodeficiency virus-negative immunodeficient patients: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijid.2022.10.004_bib0017","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2022.10.004_bib0018","doi-asserted-by":"crossref","first-page":"e13461","DOI":"10.1111\/tid.13461","article-title":"Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers","volume":"23","author":"Lum","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2022.10.004_bib0019","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2022.10.004_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.diagmicrobio.2016.10.005","article-title":"Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations","volume":"87","author":"Montesinos","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2022.10.004_bib0021","doi-asserted-by":"crossref","first-page":"e13245","DOI":"10.1111\/tid.13245","article-title":"Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: a case-control study","volume":"22","author":"Park","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2022.10.004_bib0022","doi-asserted-by":"crossref","first-page":"e13509","DOI":"10.1111\/tid.13509","article-title":"Lifelong, universal Pneumocystis jirovecii pneumonia prophylaxis: patient uptake and adherence after kidney transplant","volume":"23","author":"Peterson","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2022.10.004_bib0023","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12879-019-3944-0","article-title":"Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation","volume":"19","author":"Prasad","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2022.10.004_bib0024","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-016-1206-8","article-title":"Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial","volume":"19","author":"Utsunomiya","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijid.2022.10.004_bib0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/myc.13235","article-title":"The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation","volume":"64","author":"Yang","year":"2021","journal-title":"Mycoses"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222005434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222005434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:11:01Z","timestamp":1761120661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222005434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"alternative-id":["S1201971222005434"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.10.004","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}